Recent research focusing on Semaglutide at a dosage of 30mg is shedding new light on its potential effects. Early findings suggest that this higher dosage may amplify the drug's ability to regulate blood levels, potentially offering more significant outcomes for individuals with type 2 diabetes. Further investigation is underway to fully evaluate t